ClinVar Miner

Submissions for variant NM_000089.4(COL1A2):c.920G>A (p.Gly307Asp)

dbSNP: rs72656390
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV002231025 SCV000627359 pathogenic Osteogenesis imperfecta type I; Ehlers-Danlos syndrome, classic type, 1 2016-10-11 criteria provided, single submitter clinical testing This variant is not present in population databases (ExAC no frequency). This variant has been reported in an individual affected with osteogenesis imperfecta type IV (PMID: 17078022). For these reasons, this variant has been classified as Pathogenic. Family studies have indicated that this variant was not present in the parents of an individual with osteogenesis imperfecta, which suggests that it was de novo in that affected individual. This sequence change replaces glycine with aspartic acid at codon 307 of the COL1A2 protein (p.Gly307Asp). The glycine residue is highly conserved and there is a moderate physicochemical difference between glycine and aspartic acid.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.